72 |
Adriana D.N., Sugihartono T., Nusi I.A., Setiawan P.B., Purbayu H., Maimunah U., Kholili U., Widodo B., Thamrin H., Vidyani A., Maulahela H., Yamaoka Y., Miftahussurur M. |
Role of fecal calprotectin as a hypoxic intestinal damage biomarker in COVID-19 patients |
2022 |
Gut Pathogens |
4 |
Department of Internal Medicine, Faculty of Medicine, Soetomo Teaching Hospital, Universitas Airlangga, Dr, Surabaya, 60286, Indonesia; Gastroenterology and Hepatology Division, Department of Internal Medicine, Faculty of Medicine, Dr. Soetomo Teaching Hospital, Universitas Airlangga, Surabaya, 60286, Indonesia; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Helicobacter Pylori and Microbiota Study Group, Institute of Tropical Disease, Universitas Airlangga, Surabaya, 60115, Indonesia; Department of Environmental and Preventive Medicine, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama-machi, Oita, Yufu, 879-5593, Japan; Department of Medicine, Gastroenterology and Hepatology Section, Baylor College of Medicine, Houston, TX, United States |
Universitas Airlangga |
BioMed Central Ltd |
Q1 |
|
|